SCHEMBL5872159

SCHEMBL5872159

COC(=O)C(Cc1cc[c]c(O)c1)C(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 1/20 0.44
PPARG P37231 9/20 0.43
PPARD Q03181 5/20 0.43
PPARA Q07869 4/20 0.43
LDHA P00338 2/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
LCK P06239 1/20 0.37
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
MIF P14174 1/20 0.34
NLRP3 Q96P20 1/20 0.34
FOLH1 Q04609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871568 0.84 PTPRB (0.44) PTPRBPPARGPPARDPPARALDHA
SCHEMBL5871513 0.83 PTPRB (0.43) PTPRBPPARGPPARDPPARALDHA
SCHEMBL5872188 0.83 PTPRB (0.43) PTPRBPPARGPPARDPPARALDHA
SCHEMBL5872122 0.80 PTPRB (0.41) PTPRBPPARGPPARDPPARALDHA
SCHEMBL5871840 0.78 PTPRB (0.54) PTPRBPPARGPPARDPPARALDHA
SCHEMBL5871715 0.76 PTPRB (0.41) PTPRBPPARGPPARDPPARALDHA
SCHEMBL27424479 0.76 HSP90AB1 (0.53) ALDH1A1
SCHEMBL5871875 0.75 ESR1 (0.39) PTPRBPPARGPPARDPPARAESR1
SCHEMBL6384666 0.74 NLRP3 (0.51) PTPRBPPARGPPARDPPARAESR1
SCHEMBL27393008 0.73 SIRT2 (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071187-B2 Naphthyridine derivatives OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2006-07-04 US disclosed
US-20040214853-A1 Naphthyridine derivatives OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2004-10-28 US disclosed
EP-1426374-A1 NAPHTHYRIDINE DERIVATIVE OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214853-A1 Naphthyridine derivatives MT-ND1, OPRD1, NR0B1 PTPRB 3070/4885PPARG 1417/4885PPARD 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.